Cel-Sci
CVM
$1.72
Share price
5.52%
Change (1 day)
-31.20%
Change (1 year)
Categories
Cel-Sci (CVM) - Total debt
Total debt on the balance sheet as of December 2023 : $13.09 M
According to Cel-Sci 's latest financial reports the company's total debt is $13.09 M. A company’s total debt is the sum of all current and non-current debts.
Cel-Sci - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-09-30 | $13.57 M | -11.31% |
| 2022-09-30 | $15.3 M | -4.19% |
| 2021-09-30 | $15.97 M | 14.6% |
| 2020-09-30 | $13.93 M | 3.18% |
| 2019-09-30 | $13.5 M | 0.96% |
| 2018-09-30 | $13.37 M | -5.82% |
| 2017-09-30 | $14.2 M | 9.19% |
| 2016-09-30 | $13.01 M | -6.31% |
| 2015-09-30 | $13.88 M | 1138.19% |
| 2014-09-30 | $1.12 M | -1.02% |
| 2013-09-30 | $1.13 M | 2.64% |
| 2012-09-30 | $1.1 M | -77.91% |
| 2011-09-30 | $4.99 M | 352.78% |
| 2010-09-30 | $1.1 M | -0.3% |
| 2009-09-30 | $1.1 M | 453.67% |
| 2008-09-30 | $0.2 M | |
| 2005-09-30 | $0 M | 0% |
| 2004-09-30 | $0 M | -99.66% |
| 2003-09-30 | $0.87 M | -50.78% |
| 2002-09-30 | $1.77 M | 5583.6% |
| 2001-09-30 | $0.03 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $33.63 B | 256,648.50% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 493,159.13% | 🇺🇸 USA |
 Xencor XNCR | $83.43 M | 536.94% | 🇺🇸 USA |
 Curis CRIS | $2.79 M | -78.67% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $20.15 B | 153,749.09% | 🇮🇱 Israel |
 BioCryst Pharmaceuticals
BCRX | $0.82 B | 6,199.22% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.86 B | 6,466.81% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $41.84 M | 219.43% | 🇺🇸 USA |